Kholoud Porter

9.8k total citations
138 papers, 4.6k citations indexed

About

Kholoud Porter is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Kholoud Porter has authored 138 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Infectious Diseases, 85 papers in Virology and 41 papers in Epidemiology. Recurrent topics in Kholoud Porter's work include HIV/AIDS Research and Interventions (105 papers), HIV Research and Treatment (85 papers) and HIV/AIDS drug development and treatment (61 papers). Kholoud Porter is often cited by papers focused on HIV/AIDS Research and Interventions (105 papers), HIV Research and Treatment (85 papers) and HIV/AIDS drug development and treatment (61 papers). Kholoud Porter collaborates with scholars based in United Kingdom, France and Italy. Kholoud Porter's co-authors include Caroline Sabin, Andrew Phillips, Abdel Babiker, Krishnan Bhaskaran, Maria Dorrucci, Laurence Meyer, Margaret Johnson, Giota Touloumi, Sarah Fidler and Janet Darbyshire and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Kholoud Porter

135 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kholoud Porter United Kingdom	39	3.5k	2.5k	1.8k	1.0k	389	138	4.6k
Mauro Schechter Brazil	34	4.6k 1.3×	3.3k 1.3×	1.6k 0.9×	1.3k 1.3×	252 0.6×	71	5.6k
John S. Lambert Ireland	38	2.4k 0.7×	1.5k 0.6×	1.7k 0.9×	930 0.9×	616 1.6×	215	4.8k
Fujie Zhang China	30	3.1k 0.9×	1.4k 0.5×	1.4k 0.8×	491 0.5×	262 0.7×	179	4.1k
Diane Aschman United States	7	5.7k 1.6×	3.8k 1.5×	2.9k 1.6×	2.0k 2.0×	445 1.1×	12	7.8k
Jeanne Keruly United States	41	4.0k 1.1×	1.8k 0.7×	3.1k 1.7×	1.2k 1.2×	177 0.5×	126	5.7k
Jill Ward United States	6	2.1k 0.6×	1.3k 0.5×	1.6k 0.9×	729 0.7×	205 0.5×	11	3.9k
Shahin Lockman United States	38	3.7k 1.1×	1.5k 0.6×	1.8k 1.0×	910 0.9×	188 0.5×	232	5.6k
Jean-François Delfraissy France	14	3.4k 1.0×	1.8k 0.7×	1.5k 0.8×	788 0.8×	106 0.3×	16	4.1k
Princy Kumar United States	30	2.7k 0.8×	1.7k 0.7×	1.4k 0.8×	751 0.7×	120 0.3×	127	3.8k
AN Phillips United Kingdom	23	2.8k 0.8×	1.8k 0.7×	1.3k 0.7×	1.1k 1.1×	169 0.4×	40	3.5k

Countries citing papers authored by Kholoud Porter

Since Specialization

Citations

This map shows the geographic impact of Kholoud Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kholoud Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kholoud Porter more than expected).

Fields of papers citing papers by Kholoud Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kholoud Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kholoud Porter. The network helps show where Kholoud Porter may publish in the future.

Co-authorship network of co-authors of Kholoud Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Kholoud Porter. A scholar is included among the top collaborators of Kholoud Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kholoud Porter. Kholoud Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Safreed‐Harmon, Kelly, Jane Anderson, Natasha Azzopardi‐Muscat, et al.. (2019). Reorienting health systems to care for people with HIV beyond viral suppression. The Lancet HIV. 6(12). e869–e877. 61 indexed citations

Gourlay, Annabelle, Julie Fox, Mitzy Gafos, et al.. (2017). A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England. BMJ Open. 7(8). e016494–e016494. 14 indexed citations

Olson, Ashley, Norbert Bannert, Anders Sönnerborg, et al.. (2017). Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort. AIDS. 32(2). 161–169. 20 indexed citations

Gourlay, Annabelle, Anastasia Pharris, Teymur Noori, et al.. (2017). Towards standardized definitions for monitoring the continuum of HIV care in Europe. AIDS. 31(15). 2053–2058. 16 indexed citations

Martin, Geneviève, Morgane Gossez, James P. Williams, et al.. (2017). Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection. AIDS. 31(4). 477–484. 40 indexed citations

Fidler, Sarah, Ashley Olson, Heiner C. Bucher, et al.. (2016). Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(2). 126–133. 24 indexed citations

Simmons, Ruth, et al.. (2016). HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014. PLoS ONE. 11(6). e0157179–e0157179. 9 indexed citations

Helm, Jannie J. van der, Ronald B. Geskus, Sara Lodi, et al.. (2014). Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort study. The Lancet HIV. 1(1). e41–e48. 9 indexed citations

Rosińska, Magdalena, Joanna Smoleń‐Dzirba, Tomasz J. Wąsik, et al.. (2013). High Percentage of Recent HIV Infection Among HIV-Positive Individuals Newly Diagnosed at Voluntary Counseling and Testing Sites in Poland. AIDS Research and Human Retroviruses. 29(5). 805–813. 18 indexed citations

10.

Lodi, Sara, Andrew Phillips, Sarah Fidler, et al.. (2013). Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure. PLoS ONE. 8(9). e75608–e75608. 7 indexed citations

11.

Lodi, Sara, Martin Fisher, Andrea De Luca, et al.. (2013). Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection. PLoS ONE. 8(11). e78642–e78642. 9 indexed citations

12.

Sabin, Caroline, Valérie Delpech, Teresa Hill, et al.. (2010). Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations^*. HIV Medicine. 11(7). 432–438. 30 indexed citations

13.

Leen, Clifford, Jonathan Ainsworth, J. Anderson, et al.. (2009). Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? United Kingdom Collaborative HIV Cohort Study Group. UCL Discovery (University College London). 7 indexed citations

14.

Bower, Mark, Martin Fisher, Tetiana Hill, et al.. (2009). CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK. Haematologica. 94(6). 875–880. 45 indexed citations

15.

Gilson, Richard, Frank Post, Brian Gazzard, et al.. (2009). Is 1 Alanine Transaminase >200 IU Enough to Define an Alanine Transaminase Flare in HIV-Infected Populations? A New Definition Derived From a Large Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(3). 391–396. 3 indexed citations

16.

Ewings, Fiona M, Krishnan Bhaskaran, Ken McLean, et al.. (2008). Survival following HIV infection of a cohort followed up from seroconversion in the UK. AIDS. 22(1). 89–95. 38 indexed citations

17.

Fidler, Sarah, Julie Fox, Giota Touloumi, et al.. (2007). Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort. AIDS. 21(10). 1283–1291. 25 indexed citations

18.

Cane, Patricia, I. L. Chrystie, David Dunn, et al.. (2005). Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study. BMJ. 331(7529). 1368–1368. 146 indexed citations

19.

Bhaskaran, Krishnan, Deenan Pillay, A. Sarah Walker, et al.. (2004). Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters. AIDS. 18(10). 1471–1473. 31 indexed citations

20.

Heptonstall, J, et al.. (1993). Health care workers and HIV: surveillance of occupationally acquired infection in the United Kingdom.. PubMed. 3(11). R147–53. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact